Statin treatment in a cohort of 20 212 men and women in Norway according to cardiovascular risk factors and level of education.
about
Trends in absolute and relative educational inequalities in four modifiable ischaemic heart disease risk factors: repeated cross-sectional surveys from the Nord-Trøndelag Health Study (HUNT) 1984-2008Is the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiological cohort study.Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006-2008.Patient factors influencing the prescribing of lipid lowering drugs for primary prevention of cardiovascular disease in UK general practice: a national retrospective cohort study.Time trends in statin utilisation and coronary mortality in Western European countries.A benefit-risk assessment model for statins using multicriteria decision analysis based on a discrete choice experiment in Korean patients.Monitoring the use of lipid-lowering medication among persons with newly diagnosed diabetes: a nationwide register-based studyPotential contribution of lifestyle and socioeconomic factors to healthy user bias in antihypertensives and lipid-lowering drugs.Income differences in the type of antihypertensive medicines used in ambulatory settings in Finland: a register-based study.Trends in cardiovascular risk factors across levels of education in a general population: is the educational gap increasing? The Tromsø study 1994-2008.Cross-sectional analysis of the prevalence and predictors of statin utilisation in Ireland with a focus on primary prevention of cardiovascular disease.Attainment of optional low-density lipoprotein cholesterol goal of less than 70 mg/dl and impact on prognosis of very high risk stable coronary patients: a 3-year follow-up.
P2860
Q33353286-B5CCECF4-74F5-4338-A05F-F366B5199D6DQ34366183-96731D1C-A5CE-4A64-BE1B-5A65DD24AEDAQ34516311-54D6190D-BDB0-4229-BE7D-2894B782DD25Q34901608-0E901CAF-CA71-40E8-BCBE-C46019A81BECQ36773079-19E9ED63-E812-4D51-AD92-EF2694179568Q37016865-FDB054FB-F5D0-4662-B3C2-BBB749E80124Q37293254-D424CCA0-32D4-4D3A-99CD-59CA90C507B8Q40100271-992CD1E7-37CB-4B8A-82B5-3F52DA55C9DCQ40677101-1AF2617C-72DF-40C4-AD90-ABA96ED58225Q46502440-A080BBEC-2825-4E13-A80D-29AC0D846A9EQ50036029-17020211-C462-4EB5-8C4C-FEFD765664A2Q51372342-1112780C-A6F7-4A12-9B89-6FECE86456EC
P2860
Statin treatment in a cohort of 20 212 men and women in Norway according to cardiovascular risk factors and level of education.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Statin treatment in a cohort o ...... actors and level of education.
@en
Statin treatment in a cohort o ...... actors and level of education.
@nl
type
label
Statin treatment in a cohort o ...... actors and level of education.
@en
Statin treatment in a cohort o ...... actors and level of education.
@nl
prefLabel
Statin treatment in a cohort o ...... actors and level of education.
@en
Statin treatment in a cohort o ...... actors and level of education.
@nl
P2093
P2860
P1476
Statin treatment in a cohort o ...... actors and level of education.
@en
P2093
Randi Selmer
Solveig Sakshaug
Svetlana Skurtveit
P2860
P304
P356
10.1111/J.1365-2125.2008.03360.X
P407
P50
P577
2008-12-10T00:00:00Z